Clover Health Investments, Corp. (CLOV) shareholders
CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31
$4.88−0.09 (-1.81%)
Close on Nov 12, 2026Market cap $2.59BP/E 488.0Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
27.5%
146M of 531M shares
Institutional holders
225
45 new, 25 sold out
Net institutional buying
19M
In Q2 2026
Insider trades, 12 months
0 buys · 41 sales
Net sold $8.71M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 29,813,646 | 7.20% | 13G (passive) | Jun 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CLOV | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 35,106,965 | 6.61% | $183.96M | +3,266,453 | 0.00% |
| Vanguard Capital Management LLC | 18,037,661 | 3.40% | $94.52M | +1,055,588 | 0.00% |
| Geode Capital Management, LLC | 10,846,066 | 2.04% | $56.84M | +790,556 | 0.00% |
| State Street Corp | 10,180,337 | 1.92% | $53.34M | +620,448 | 0.00% |
| Nuveen, LLC | 6,291,699 | 1.18% | $32.97M | +5,356,156 | 0.01% |
| Charles Schwab Investment Management Inc | 5,521,188 | 1.04% | $28.93M | +220,713 | 0.00% |
| Vanguard Portfolio Management LLC | 4,470,452 | 0.84% | $23.43M | +774,015 | 0.00% |
| Northern Trust Corp | 3,772,600 | 0.71% | $19.77M | +466,025 | 0.00% |
| PNC Financial Services Group, Inc. | 3,563,874 | 0.67% | $18.67M | −200,160 | 0.01% |
| Dimensional Fund Advisors LP | 3,148,626 | 0.59% | $16.50M | −269,240 | 0.00% |
| Vanguard Fiduciary Trust Co | 2,919,893 | 0.55% | $15.30M | +113,683 | 0.00% |
| Renaissance Technologies LLC | 2,807,441 | 0.53% | $14.71M | −594,100 | 0.02% |
| Morgan Stanley | 2,294,305 | 0.43% | $12.02M | +107,881 | 0.00% |
| Citadel Advisors LLC | 2,163,205 | 0.41% | $11.34M | +285,157 | 0.00% |
| D. E. Shaw & Co., Inc. | 1,965,493 | 0.37% | $10.30M | +1,874,482 | 0.00% |
| Marshall Wace, Llp | 1,563,189 | 0.29% | $8.19M | New | 0.01% |
| Invesco Ltd. | 1,336,790 | 0.25% | $7.00M | +308,419 | 0.00% |
| Gmt Capital Corp | 1,305,200 | 0.25% | $6.84M | – | 0.36% |
| Mackenzie Financial Corp | 1,297,476 | 0.24% | $6.80M | New | 0.01% |
| Jane Street Group, LLC | 1,291,443 | 0.24% | $6.77M | +250,039 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 225 | 146M | 27.5% | 45 / 77 | 54 / 25 | 27M | 9M |
| Q1 2026 | 208 | 127M | 24.0% | 46 / 57 | 53 / 27 | 35M | 11M |
| Q4 2025 | 192 | 126M | 23.8% | 30 / 61 | 54 / 37 | 10M | 19M |
| Q3 2025 | 201 | 136M | 25.6% | 30 / 59 | 59 / 28 | 14M | 25M |
| Q2 2025 | 200 | 146M | 27.6% | 52 / 69 | 36 / 50 | 57M | 17M |
| Q1 2025 | 202 | 106M | 20.0% | 55 / 47 | 57 / 27 | 20M | 6M |
| Q4 2024 | 178 | 93M | 17.5% | 39 / 62 | 33 / 20 | 19M | 8M |
| Q3 2024 | 159 | 82M | 15.5% | 56 / 35 | 32 / 23 | 26M | 7M |
| Q2 2024 | 127 | 73M | 13.8% | 25 / 27 | 34 / 33 | 5M | 24M |
| Q1 2024 | 137 | 92M | 17.3% | 15 / 40 | 34 / 20 | 11M | 17M |
| Q4 2023 | 144 | 97M | 18.3% | 26 / 40 | 35 / 23 | 19M | 15M |
| Q3 2023 | 143 | 94M | 17.6% | 23 / 35 | 36 / 23 | 8M | 11M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
144 funds held CLOV in Q2 2026, 69% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CLOV | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 12,979,049 | 2.44% | $68.01M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 10,799,640 | 2.03% | $56.59M | 0.07% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 4,646,552 | 0.87% | $24.35M | 0.02% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 4,600,368 | 0.87% | $19.18M | 0.06% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 3,884,505 | 0.73% | $20.35M | 0.13% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 2,099,735 | 0.40% | $8.36M | 0.05% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 2,069,070 | 0.39% | $8.23M | 0.02% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 1,928,726 | 0.36% | $7.68M | 0.03% | May 31, 2026 |
| College Retirement Equities Fund - Total Global Stock Account | 1,846,270 | 0.35% | $9.67M | 0.01% | Jun 30, 2026 |
| Nuveen Quant Small Cap Equity Fund | 1,782,220 | 0.34% | $7.43M | 0.18% | Jul 31, 2026 |
| Nuveen Quant Small/Mid Cap Equity Fund | 1,474,500 | 0.28% | $6.15M | 0.23% | Jul 31, 2026 |
| Schwab Fundamental U.S. Small Company ETF | 1,399,574 | 0.26% | $5.57M | 0.06% | May 31, 2026 |
| Vanguard Health Care Index Fund | 1,273,572 | 0.24% | $5.07M | 0.03% | May 31, 2026 |
| Schwab Small-Cap Index Fund | 1,021,380 | 0.19% | $4.26M | 0.06% | Jul 31, 2026 |
| U.S. Micro Cap Portfolio | 938,222 | 0.18% | $3.91M | 0.05% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Andrew Toy | Chief Executive Officer, Director | 9,078,334 | 1.71% | Oct 19, 2026 |
| Joseph Frank Oldakowski | Chief Accounting Officer | 462,300 | 0.09% | Nov 6, 2026 |
| Joseph Clay Thornton | Chief Financial Officer | 1,573,882 | 0.30% | Nov 6, 2026 |
| Jamie L. Reynoso | CEO, Medicare Advantage | 2,770,351 | 0.52% | Oct 20, 2026 |
| Karen Soares | Chief Legal Officer | 1,573,423 | 0.30% | Oct 20, 2026 |
| Conrad Wai | CEO, Counterpart Health | 2,212,128 | 0.42% | Oct 19, 2026 |
| Brady Patrick Priest | CEO of Clover Care Services | 2,040,222 | 0.38% | May 13, 2026 |
| Peter J. Kuipers | Chief Financial Officer | 5,758,353 | 1.08% | Feb 2, 2026 |
| Robert G. Torricelli | Director | 186,897 | 0.04% | Oct 2, 2026 |
| Brian James Miller | Director | 12,481 | 0.00% | Oct 2, 2026 |
| Carladenise Armbrister Edwards | Director | 285,432 | 0.05% | May 19, 2026 |
| Vivek Garipalli | Director, 10% owner | 95,687,832 | 18.02% | Jan 9, 2026 |
| Thomas L. Tran | Director | 180,029 | 0.03% | Jan 8, 2026 |
| William G. Robinson Jr | Director | 597,987 | 0.11% | Jan 8, 2026 |
| Demetrios L. Kouzoukas | Director | 605,980 | 0.11% | Jan 8, 2026 |
| Anna U. Loengard | Director | 584,666 | 0.11% | Jan 8, 2026 |
| Lee Shapiro | Director | 598,622 | 0.11% | Jan 8, 2025 |
| Chelsea Clinton | Director | 602,814 | 0.11% | Jan 8, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Joseph Frank Oldakowski Chief Accounting Officer | Nov 4, 2026 | Award | +186,403 | – | – | 462,300 |
| Joseph Clay Thornton Chief Financial Officer | Nov 4, 2026 | Award | +328,947 | – | – | 1,573,882 |
| Karen Soares Chief Legal Officer | Oct 20, 2026 | Sale(10b5-1 plan) | −19,275 | $4.66 | $89.82K | 1,573,423 |
| Jamie L. Reynoso CEO, Medicare Advantage | Oct 19, 2026 | Sale(10b5-1 plan) | −4,066 | $4.41 | $17.93K | 2,770,351 |
| Andrew Toy Chief Executive Officer, Director | Oct 15, 2026 | Sale(10b5-1 plan) | −62,176 | $4.68 | $290.98K | 9,078,334 |
| Karen Soares Chief Legal Officer | Oct 15, 2026 | Sale(10b5-1 plan) | −14,673 | $4.68 | $68.67K | 1,592,698 |
| Joseph Clay Thornton Interim CFO | Oct 15, 2026 | Sale(10b5-1 plan) | −4,591 | $4.68 | $21.49K | 1,244,935 |
| Conrad Wai CEO, Counterpart Health | Oct 15, 2026 | Sale(10b5-1 plan) | −23,627 | $4.68 | $110.57K | 1,042,072 |
| Jamie L. Reynoso CEO, Medicare Advantage | Oct 15, 2026 | Sale(10b5-1 plan) | −18,273 | $4.68 | $85.52K | 2,774,417 |
| Jamie L. Reynoso CEO, Medicare Advantage | Oct 7, 2026 | Sale(10b5-1 plan) | −2,006 | $4.63 | $9.29K | 2,792,690 |
| Jamie L. Reynoso CEO, Medicare Advantage | Oct 5, 2026 | Sale(10b5-1 plan) | −8,750 | $4.42 | $38.68K | 2,794,696 |
| Andrew Toy Chief Executive Officer, Director | Oct 1, 2026 | Sale(10b5-1 plan) | −318,806 | $4.19 | $1.34M | 9,140,510 |
| Brian James Miller Director | Sep 30, 2026 | Award | +12,481 | – | – | 12,481 |
| Robert G. Torricelli Director | Sep 30, 2026 | Award | +12,481 | – | – | 186,897 |
| Jamie L. Reynoso CEO, Medicare Advantage | Sep 17, 2026 | Sale(10b5-1 plan) | −1,921 | $4.56 | $8.76K | 2,803,446 |
| Joseph Frank Oldakowski VP OF FINANCE AND CONTROLLER | Sep 16, 2026 | Sale(10b5-1 plan) | −3,170 | $4.64 | $14.71K | 275,897 |
| Conrad Wai CEO, Counterpart Health | Sep 15, 2026 | Sale(10b5-1 plan) | −300,000 | $4.72 | $1.42M | 1,170,056 |
| Karen Soares Chief Legal Officer | Sep 15, 2026 | Sale(10b5-1 plan) | −6,846 | $4.78 | $32.72K | 1,607,371 |
| Jamie L. Reynoso CEO, Medicare Advantage | Sep 15, 2026 | Sale(10b5-1 plan) | −9,273 | $4.78 | $44.32K | 2,805,367 |
| Joseph Frank Oldakowski VP OF FINANCE AND CONTROLLER | Sep 14, 2026 | Sale | −20,000 | $5.16 | $103.20K | 279,067 |
| Joseph Clay Thornton Interim CFO | Aug 17, 2026 | Sale(10b5-1 plan) | −17,775 | $4.39 | $78.03K | 1,249,526 |
| Karen Soares Chief Legal Officer | Aug 12, 2026 | Award | +108,695 | – | – | 1,614,217 |
| Joseph Clay Thornton Interim CFO | Aug 12, 2026 | Award | +54,347 | – | – | 1,267,301 |
| Andrew Toy Chief Executive Officer, Director | Aug 10, 2026 | Sale(10b5-1 plan) | −87,798 | $4.65 | $408.26K | 9,459,316 |
| Karen Soares Chief Legal Officer | Jul 20, 2026 | Sale(10b5-1 plan) | −51,700 | $4.51 | $233.17K | 1,505,522 |
| Jamie L. Reynoso CEO, Medicare Advantage | Jul 17, 2026 | Sale(10b5-1 plan) | −4,839 | $4.53 | $21.92K | 2,814,640 |
| Andrew Toy Chief Executive Officer, Director | Jul 15, 2026 | Sale(10b5-1 plan) | −62,711 | $4.67 | $292.86K | 9,547,114 |
| Jamie L. Reynoso CEO, Medicare Advantage | Jul 15, 2026 | Sale(10b5-1 plan) | −13,119 | $4.67 | $61.27K | 2,819,479 |
| Conrad Wai CEO, Counterpart Health | Jul 15, 2026 | Sale(10b5-1 plan) | −24,215 | $4.67 | $113.08K | 1,145,699 |
| Karen Soares Chief Legal Officer | Jul 15, 2026 | Sale(10b5-1 plan) | −10,519 | $4.67 | $49.12K | 1,557,222 |
| Joseph Clay Thornton Interim CFO | Jul 15, 2026 | Sale(10b5-1 plan) | −4,630 | $4.67 | $21.62K | 1,212,954 |
| Jamie L. Reynoso CEO, Medicare Advantage | Jul 8, 2026 | Sale(10b5-1 plan) | −2,384 | $4.68 | $11.16K | 2,832,598 |
| Jamie L. Reynoso CEO, Medicare Advantage | Jul 6, 2026 | Sale(10b5-1 plan) | −6,229 | $5.26 | $32.76K | 2,834,982 |
| Andrew Toy Chief Executive Officer, Director | Jul 1, 2026 | Sale(10b5-1 plan) | −313,476 | $5.32 | $1.67M | 9,609,825 |
| Jamie L. Reynoso CEO, Medicare Advantage | Jun 17, 2026 | Sale(10b5-1 plan) | −2,360 | $4.78 | $11.28K | 2,841,211 |
| Joseph Frank Oldakowski VP OF FINANCE AND CONTROLLER | Jun 16, 2026 | Sale(10b5-1 plan) | −12,102 | $4.86 | $58.82K | 299,067 |
| Jamie L. Reynoso CEO, Medicare Advantage | Jun 15, 2026 | Sale(10b5-1 plan) | −6,350 | $4.61 | $29.27K | 2,843,571 |
| Karen Soares Chief Legal Officer | Jun 15, 2026 | Sale(10b5-1 plan) | −4,681 | $4.61 | $21.58K | 1,567,741 |
| Jamie L. Reynoso CEO, Medicare Advantage | Jun 11, 2026 | Sale(10b5-1 plan) | −7,289 | $4.91 | $35.79K | 2,849,921 |
| Conrad Wai CEO, Counterpart Health | May 28, 2026 | Sale(10b5-1 plan) | −220,426 | $3.99 | $879.50K | 1,390,056 |
| Carladenise Armbrister Edwards Director | May 18, 2026 | Sale | −67,160 | $3.42 | $229.69K | 285,432 |
| Joseph Clay Thornton Interim CFO | May 16, 2026 | Tax withholding | −16,942 | $3.47 | $58.79K | 1,217,584 |
| Brady Patrick Priest CEO of Clover Care Services | May 13, 2026 | Sale | −98,039 | $3.52 | $345.10K | 2,040,222 |
| Andrew Toy Chief Executive Officer, Director | May 8, 2026 | Tax withholding | −85,704 | $2.82 | $241.69K | 9,923,301 |
| Brady Patrick Priest CEO of Clover Care Services | Apr 18, 2026 | Tax withholding | −36,113 | $2.19 | $79.09K | 2,138,261 |
| Joseph Clay Thornton Interim CFO | Apr 15, 2026 | Tax withholding | −4,158 | $2.04 | $8.48K | 1,234,526 |
| Conrad Wai CEO, Counterpart Health | Apr 15, 2026 | Tax withholding | −23,463 | $2.04 | $47.86K | 1,169,914 |
| Jamie L. Reynoso CEO, Medicare Advantage | Apr 15, 2026 | Tax withholding | −12,712 | $2.04 | $25.93K | 2,857,210 |
| Andrew Toy Chief Executive Officer, Director | Apr 15, 2026 | Tax withholding | −60,765 | $2.04 | $123.96K | 10,009,005 |
| Karen Soares Chief Legal Officer | Apr 15, 2026 | Tax withholding | −10,161 | $2.04 | $20.73K | 1,572,422 |
| Brady Patrick Priest CEO of Clover Care Services | Apr 15, 2026 | Tax withholding | −15,471 | $2.04 | $31.56K | 2,174,374 |
| Jamie L. Reynoso CEO, Medicare Advantage | Apr 3, 2026 | Tax withholding | −6,197 | $1.72 | $10.66K | 2,869,922 |
| Karen Soares Chief Legal Officer | Apr 1, 2026 | Award | +382,522 | – | – | 1,582,583 |
| Jamie L. Reynoso CEO, Medicare Advantage | Apr 1, 2026 | Award | +159,384 | – | – | 2,876,119 |
| Brady Patrick Priest CEO of Clover Care Services | Apr 1, 2026 | Award | +191,261 | – | – | 2,189,845 |
| Conrad Wai CEO, Counterpart Health | Apr 1, 2026 | Award | +267,766 | – | – | 1,193,377 |
| Andrew Toy Chief Executive Officer, Director | Apr 1, 2026 | Tax withholding | −309,558 | $1.76 | $544.82K | 10,069,770 |
| Andrew Toy Chief Executive Officer, Director | Apr 1, 2026 | Award | +956,307 | – | – | 10,379,328 |
| Jamie L. Reynoso CEO, Medicare Advantage | Mar 18, 2026 | Sale(10b5-1 plan) | −5,833 | $1.91 | $11.14K | 2,716,735 |
| Jamie L. Reynoso CEO, Medicare Advantage | Mar 15, 2026 | Tax withholding | −6,187 | $1.98 | $12.25K | 2,722,568 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
5.67%
23M shares short
Days to cover
6.7
At 3M shares a day
Change since last report
-11.3%
From 26M shares
Short volume, 20 days
37.5%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Clover Health Investments's stock actually held short. Settlement fails (shares not delivered on time) peaked at 22,868 shares on Sep 30, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Karen Soares Officer | Oct 20, 2026 | 19,275 | $85.58K | Oct 20, 2026 | Restricted Stock Units |
| Jamie L. Reynoso Officer | Oct 19, 2026 | 4,066 | $18.22K | Oct 19, 2026 | Restricted Stock Units |
| Jamie L. Reynoso Officer | Oct 15, 2026 | 17,858 | $83.58K | Oct 15, 2026 | Restricted Stock Units |
| Karen Soares Officer | Oct 15, 2026 | 14,341 | $67.12K | Oct 15, 2026 | Restricted Stock Units |
| Conrad Wai Officer | Oct 15, 2026 | 23,463 | $109.81K | Oct 15, 2026 | Restricted Stock Units |
| Joseph Clay Thornton Officer | Oct 15, 2026 | 4,487 | $21.00K | Oct 15, 2026 | Restricted Stock Units |
| Andrew Toy Officer | Oct 15, 2026 | 60,765 | $284.38K | Oct 15, 2026 | Restricted Stock Units |
| Jamie L. Reynoso Officer | Oct 7, 2026 | 2,006 | $9.23K | Oct 7, 2026 | Restricted Stock Units |
| Jamie L. Reynoso Officer | Oct 5, 2026 | 8,706 | $40.74K | Oct 5, 2026 | Restricted Stock Units |
| Andrew Toy Officer | Oct 1, 2026 | 309,558 | $1.31M | Oct 1, 2026 | Restricted Stock Units |
| Brady Patrick Priest Former Officer | Sep 24, 2026 | 141,418 | $631.16K | Sep 24, 2026 | Restricted Stock |
| Jamie L. Reynoso Officer | Sep 17, 2026 | 1,921 | $8.76K | Sep 17, 2026 | Restricted Stock Units |
| Joseph Frank Oldakowski Officer | Sep 16, 2026 | 3,170 | $14.71K | Sep 16, 2026 | Restricted Stock Units |
| Karen Soares Officer | Sep 15, 2026 | 6,416 | $29.90K | Sep 15, 2026 | Restricted Stock Units |
| Jamie L. Reynoso Officer | Sep 15, 2026 | 8,691 | $40.50K | Sep 15, 2026 | Restricted Stock Units |
See a number that looks wrong?